Literature DB >> 2851445

Phase II trial of mitoxantrone in patients with hepatocellular carcinoma.

T Yoshida1, N Okazaki, M Yoshino, H Ohkura, K Miyamoto, Y Shimada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2851445     DOI： 10.1016/0277-5379(88)90104-6

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  3 in total

Review 1.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  D Faulds; J A Balfour; P Chrisp; H D Langtry
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

2.  Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry.

Authors:  C J Twelves; S M O'Reilly; R E Coleman; M A Richards; R D Rubens
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

3.  Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.

Authors:  M Mabed; L El-Helw; S Shamaa
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.